Barclays’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-38
| Closed | – | – | 4017 |
|
|
2020
Q4 | $0 | Hold |
38
| – | – | ﹤0.01% | 3780 |
|
|
2020
Q3 | $0 | Hold |
38
| – | – | ﹤0.01% | 4052 |
|
|
2020
Q2 | $0 | Hold |
38
| – | – | ﹤0.01% | 4060 |
|
|
2020
Q1 | $0 | Sell |
38
-40
| -51% | – | ﹤0.01% | 4060 |
|
|
2019
Q4 | $0 | Sell |
78
-43
| -36% | – | ﹤0.01% | 4434 |
|
|
2019
Q3 | $0 | Sell |
121
-34,998
| -100% | – | ﹤0.01% | 4579 |
|
|
2019
Q2 | $45K | Buy |
35,119
+21,632
| +160% | +$27.7K | ﹤0.01% | 3863 |
|
|
2019
Q1 | $35K | Buy |
13,487
+13,406
| +16,551% | +$34.8K | ﹤0.01% | 3785 |
|
|
2018
Q4 | $0 | Sell |
81
-11,634
| -99% | – | ﹤0.01% | 4568 |
|
|
2018
Q3 | $57K | Buy |
11,715
+9,605
| +455% | +$46.7K | ﹤0.01% | 3699 |
|
|
2018
Q2 | $13K | Sell |
2,110
-9,893
| -82% | -$61K | ﹤0.01% | 3822 |
|
|
2018
Q1 | $100K | Buy |
12,003
+6,277
| +110% | +$52.3K | ﹤0.01% | 3169 |
|
|
2017
Q4 | $59K | Sell |
5,726
-6,855
| -54% | -$70.6K | ﹤0.01% | 3283 |
|
|
2017
Q3 | $115K | Buy |
12,581
+6,590
| +110% | +$60.2K | ﹤0.01% | 2652 |
|
|
2017
Q2 | $44K | Sell |
5,991
-9,237
| -61% | -$67.8K | ﹤0.01% | 3060 |
|
|
2017
Q1 | $110K | Buy |
15,228
+11,266
| +284% | +$81.4K | ﹤0.01% | 2795 |
|
|
2016
Q4 | $22K | Buy |
3,962
+3,876
| +4,507% | +$21.5K | ﹤0.01% | 3067 |
|
|
2016
Q3 | $1K | Sell |
86
-100
| -54% | -$1.16K | ﹤0.01% | 3844 |
|
|
2016
Q2 | $2K | Buy |
186
+100
| +116% | +$1.08K | ﹤0.01% | 3333 |
|
|
2016
Q1 | $1K | Sell |
86
-179
| -68% | -$2.08K | ﹤0.01% | 3374 |
|
|
2015
Q4 | $3K | Buy |
+265
| New | +$3K | ﹤0.01% | 3003 |
|